§ Mr. CohenTo ask the Secretary of State for Health what assessment his Department has made of the risk of myelography causing arachnoiditis; and if he will make a statement. [42391]
§ Ms JowellAny injury to the arachnoid membrane carries a risk of arachnoiditis. However, all medicinal products, such as the contrast agents used in myelography, are subject to stringent assessment of safety, quality and efficacy prior to being licensed. They are closely monitored by the Medicines Control Agency after licensing to detect any previously unrecognised adverse effects or any change in the balance of risks and benefits.